Dual Anti-HER2 Therapy (Lapatinib and Trastuzumab) Plus Chemotherapy in HER2-positive MBC
Clinical trial NCT04001634 · COMPLETED
Trial details
- NCT number
- NCT04001634
- Sponsor
- Fudan University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-01-01
- Primary completion
- 2019-05-15
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.